Pharma Major Lupin Limited reported its performance for the third quarter ending
31st December, 2015. These unaudited results were taken on record by the Board of Directors at a meeting in
Pharma Major Lupin Limited (Lupin) announced today that its US
subsidiary, Lupin Pharmaceuticals Inc. has launched its Metformin HCl ER Tablets, 500 mg and 1000 mg to
market a generic equivalent of Santarus Inc.'s Glumetza® HCl ER Tablets, 500 mg and 1000 mg.
Pharma Major Lupin Limited (Lupin) announced that it has received final
approval for its KaitlibTM Fe Tablets (Norethindrone and Ethinyl Estradiol Chewable Tablets, 0.8 mg/0.025 mg and
Ferrous Fumarate Chewable Tablets, 75 mg) from the United States Food and Drug Administration (FDA)